Drug Patents owned by Sanofi

1. Drug name - RENVELA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7985418 SANOFI Aliphatic amine polymer salts for tableting Oct, 2025

(3 years from now)

More Information on Dosage
Strength Dosage Availability
800MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.